Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded Revision: v3.5.0. Removed Revision: v3.4.3.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.1%

- Check80 days agoChange DetectedGlossary toggle controls were added (Show glossary / Hide glossary) and the footer now includes a revision tag (Revision: v3.4.0) along with updated QC criteria text and a No FEAR Act Data notice.SummaryDifference0.3%

- Check87 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a metadata update rather than a modification of study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.